{"abstract":"The Food and Drug Administration (FDA, the Agency, or we) is announcing a public hearing on the potential future therapeutic use of psychedelic drugs. In collaboration with federal partners, FDA is holding this public hearing to obtain feedback and perspectives on issues associated with the potential future therapeutic use of drug products containing a psychedelic drug substance in supervised and supportive settings.","action":"Public hearing; request for comments.","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"Food and Drug Administration","name":"Food and Drug Administration","id":199,"url":"https://www.federalregister.gov/agencies/food-and-drug-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/199","parent_id":221,"slug":"food-and-drug-administration"}],"body_html_url":"https://www.federalregister.gov/documents/full_text/html/2026/07/14/2026-14155.html","cfr_references":[],"citation":"91 FR 43095","comment_url":"http://www.regulations.gov/commenton/FDA-2026-N-7542-0001","comments_close_on":null,"correction_of":null,"corrections":[],"dates":"The public hearing will be held with an in-person and virtual option (i.e., hybrid) on September 14, 2026, from 12:30 p.m. to 4:30 p.m. Eastern Time. Registration, including requests to present at the public hearing, must be completed through the meeting registration page at www.fda.gov/news-events/fda-meetings-conferences-and-workshops/ considerations-potential-future-therapeutic-use-psychedelic-drugs- public-hearing-09142026 by 11:59 p.m. Eastern Time on August 21, 2026. Questions about registration and participation should be sent to PsychedelicsHearing@fda.hhs.gov and should include the title of this notice. See the SUPPLEMENTARY INFORMATION section for attendance and registration information.","disposition_notes":null,"docket_ids":["Docket No. FDA-2026-N-7542"],"dockets":[{"supporting_documents":[],"agency_name":"FDA","documents":[{"comment_count":162,"comment_start_date":"2026-07-14","updated_at":"2026-09-22T01:56:31.120-04:00","comment_url":"https://www.regulations.gov/commenton/FDA-2026-N-7542-0001","allow_late_comments":false,"id":"FDA-2026-N-7542-0001","comment_end_date":"2026-10-06","regulations_dot_gov_open_for_comment":true}],"supporting_documents_count":0,"id":"FDA-2026-N-7542","title":"Considerations for Potential Future Therapeutic Use of Psychedelic Drugs; Public Hearing; Request for Comments"}],"document_number":"2026-14155","effective_on":null,"end_page":43098,"executive_order_notes":null,"executive_order_number":null,"full_text_xml_url":"https://www.federalregister.gov/documents/full_text/xml/2026/07/14/2026-14155.xml","html_url":"https://www.federalregister.gov/documents/2026/07/14/2026-14155/considerations-for-potential-future-therapeutic-use-of-psychedelic-drugs-public-hearing-request-for","images":{},"images_metadata":{},"json_url":"https://www.federalregister.gov/api/v1/documents/2026-14155?publication_date=2026-07-14","mods_url":"https://www.govinfo.gov/metadata/granule/FR-2026-07-14/2026-14155/mods.xml","not_received_for_publication":null,"page_length":4,"page_views":{"count":4929,"last_updated":"2026-09-22 06:15:08 -0400"},"pdf_url":"https://www.govinfo.gov/content/pkg/FR-2026-07-14/pdf/2026-14155.pdf","presidential_document_number":null,"proclamation_number":null,"public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2026-14155.pdf?1783946716","publication_date":"2026-07-14","raw_text_url":"https://www.federalregister.gov/documents/full_text/text/2026/07/14/2026-14155.txt","regulation_id_number_info":{},"regulation_id_numbers":[],"regulations_dot_gov_info":{"supporting_documents":[],"comments_count":162,"agency_id":"FDA","comments_url":"https://www.regulations.gov/docketBrowser?rpp=50&so=DESC&sb=postedDate&po=0&dct=PS&D=FDA-2026-N-7542","supporting_documents_count":0,"docket_id":"FDA-2026-N-7542","document_id":"FDA-2026-N-7542-0001","regulation_id_number":null,"title":"Considerations for Potential Future Therapeutic Use of Psychedelic Drugs; Public Hearing; Request for Comments","checked_regulationsdotgov_at":"2026-09-22T09:55:07Z"},"regulations_dot_gov_url":"http://www.regulations.gov/commenton/FDA-2026-N-7542-0001","significant":null,"signing_date":null,"start_page":43095,"subtype":null,"title":"Considerations for Potential Future Therapeutic Use of Psychedelic Drugs; Public Hearing; Request for Comments","toc_doc":"Considerations for Potential Future Therapeutic Use of Psychedelic Drugs","toc_subject":"Hearings, Meetings, Proceedings, etc.","topics":[],"type":"Notice","volume":91}